Hypera S.A. (OTCMKTS:HYPMY) Short Interest Update

Hypera S.A. (OTCMKTS:HYPMY) was the recipient of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 11,600 shares, a decrease of 71.6% from the November 15th total of 40,900 shares. Based on an average daily trading volume, of 84,900 shares, the days-to-cover ratio is currently 0.1 days.

Hypera Trading Up 3.4 %

Hypera stock traded up $0.10 during mid-day trading on Wednesday, hitting $3.20. 6,876 shares of the company’s stock were exchanged, compared to its average volume of 78,994. Hypera has a 1-year low of $3.07 and a 1-year high of $7.90. The stock has a 50 day moving average of $3.98 and a two-hundred day moving average of $4.80.

Hypera Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.